Results 1 to 10 of about 190 (94)

Computational Study on the Inhibitory Effect of Natural Compounds against the SARS-CoV-2 Proteins [PDF]

Bioinorganic Chemistry and Applications, 2022
COVID-19 is more virulent and challenging to human life. In India, the Ministry of AYUSH recommended some strategies through Siddha, homeopathy, and other methods to effectively manage COVID-19 (Guidelines for AYUSH Clinical Studies in COVID-19, 2020 ...
John Marshal Jayaraj, Muralidharan Jothimani, Chella Perumal Palanisamy, Olli T. Pentikäinen, Mehboobali Pannipara, Abdullah G. Al-Sehemi, Karthikeyan Muthusamy, Krishnasamy Gopinath   +7 more
doaj   +5 more sources

Effectiveness of Kabasura Kudineer tablets in the management of asymptomatic and mild cases of COVID-19: A pilot double-blinded, randomized controlled trial [PDF]

Journal of Ayurveda and Integrative Medicine, 2023
Introduction: COVID-19 was declared a pandemic in 2020. It has had a devastating effect on human life and the global economy. To date, there is no proven therapy for COVID-19, even though rigorous research is ongoing to test multiple compounds across all
Balram Ji Omar, Meenakshi Khapre, Smita Sinha   +2 more
exaly   +6 more sources

In Silico computational screening of Kabasura Kudineer - Official Siddha Formulation and JACOM against SARS-CoV-2 spike protein [PDF]

Journal of Ayurveda and Integrative Medicine, 2022
Background: Siddha Medicine is a valuable therapeutic choice which is classically used for treating viral respiratory infections, this principle of medicine is proven to contain antiviral compounds.
Gangarapu Kiran, Karthik Loganathan, K M Kumar   +2 more
exaly   +6 more sources

Molecular Docking Studies on the Anti-viral Effects of Compounds From Kabasura Kudineer on SARS-CoV-2 3CLpro [PDF]

Frontiers in Molecular Biosciences, 2020
The COVID-19 has now been declared a global pandemic by the World Health Organization. No approved drug is currently available; therefore, an urgent need has been developed for any antiviral therapy for COVID-19.
Saravanan Muthupandian, Selvaraj Arokiyaraj, Savariar Vincent   +2 more
exaly   +7 more sources

The GC-MS Analysis of Kabasura Kudineer: A Vital Siddha Drug in COVID-19 Therapy

Journal of Pharmacy and Bioallied Sciences
IntroductionThis study focuses on the gas chromatography-mass spectrometry (GC-MS) analysis of Kabasura Kudineer, a Siddha formulation renowned for its properties against cold and exclusively utilized during the coronavirus disease 2019 (COVID-19 ...
Sumathi Jones, K Prabhu
exaly   +6 more sources

Antidiabetic activity of Kabasura Kudineer Chooranam [PDF]

Journal of Advanced Pharmaceutical Technology & Research, 2022
One of the traditional plants used in Siddha medicine is Kabasura Kudineer Chooranam. It is said to possess antiaging, life-strengthening, and disease-preventing activities that have an enormous influence on health care.
P Harini, Vishnu Priya Veeraraghavan, J Selvaraj, R Gayathri, S Kavitha   +4 more
doaj   +4 more sources

In vivo efficacy and safety of Siddha medicine Kabasura Kudineer among COVID 19 infected Syrian golden hamsters. [PDF]

Journal for Educators, Teachers and Trainers, 2021
Introduction: Kabasura kudineer is a concoction prepared as a siddha product which is effective against respiratory infection (1). It is made with the use of 15 herbs which includes ginger, clove, Piper Longum, Dusparsha, Akarakarabha, Kokilaksha, haritaki, Malabar nut, ajwain, Kusta, guduchi, Kalamegha,Raja pata, musta and Bharani (2).
Divya K, Pathak J, Reddy RKM, R VHK.
europepmc   +12 more sources

Evaluating the Antiviral Potential of Polyherbal Formulation (Kabasura Kudineer) Against Monkeypox Virus: Targeting E5, Poxin, and DNA Polymerase Through Multifaceted Drug Discovery Approaches [PDF]

Life
The recent reemergence of the monkeypox pandemic in non-endemic regions has raised serious concerns regarding the possibility of a global outbreak. The study employed various modules of the Schrodinger suite through Maestro V 14.1 for molecular docking ...
Sivan Padma Priya, Singamoorthy Amalraj, Vivek Padmanabhan, Mohammed Mustahsen Rahman, Nallan CSK Chaitanya, Nada Tawfig Hashim, Srinivasan Prabhu, Muniappan Ayyanar, Shailendra Gurav, Stanislaus Antony Ceasar, Rekha Thiruvengadam   +10 more
doaj   +4 more sources

Kabasura Kudineer (KSK), a poly-herbal Siddha medicine, reduced SARS-CoV-2 viral load in asymptomatic COVID-19 individuals as compared to vitamin C and zinc supplementation: findings from a prospective, exploratory, open-labeled, comparative, randomized controlled trial, Tamil Nadu, India [PDF]

Trials, 2021
Introduction Despite several ongoing efforts in biomedicine and traditional medicine, there are no drugs or vaccines for coronavirus disease 2019 (COVID-19) as of May 2020; Kabasura Kudineer (KSK), a polyherbal formulation from India’s Siddha system of ...
S. Natarajan, C. Anbarasi, P. Sathiyarajeswaran, P. Manickam, S. Geetha, R. Kathiravan, P. Prathiba, M. Pitchiahkumar, P. Parthiban, K. Kanakavalli, P. Balaji   +10 more
doaj   +2 more sources

The efficacy of Siddha Medicine, Kabasura Kudineer (KSK) compared to Vitamin C & Zinc (CZ) supplementation in the management of asymptomatic COVID-19 cases: A structured summary of a study protocol for a randomised controlled trial [PDF]

Trials, 2020
Objectives The primary objectives of this study are to determine efficacy of Siddha medicine, Kabasura kudineer in reduction of SARS-CoV-2 viral load and reducing the onset of symptoms in asymptomatic COVID-19 when compared to Vitamin C and Zinc (CZ ...
S. Natarajan, C. Anbarasi, P. Sathiyarajeswaran, P. Manickam, S. Geetha, R. Kathiravan, P. Prathiba, M. Pitchiahkumar, P. Parthiban, K. Kanakavalli, P. Balaji   +10 more
doaj   +2 more sources